Chief Executive Officer
Darin Hammers has served as Chief Executive Officer of the Company since September 2018. Mr. Hammers’ experience includes over 25 years of increasing leadership roles in Gynecology and Urology. Prior to joining DYSIS, he served as the President and CEO of Cogentix Medical which was acquired by Laborie in April of 2018. He joined Cogentix’s predecessor company Uroplasty as Vice President of Global Sales in January 2013 and was promoted to Chief Operating Officer prior to being named interim President and CEO in May 2016, and President and CEO in July 2016. Prior to joining Uroplasty, Mr. Hammers was Vice President of Sales for Bard Medical Division of C.R. Bard based in Covington, GA, focused on Urology care products. Prior to that, Mr. Hammers spent more than 12 years with Boston Scientific in various sales leadership positions in the Urology/Gynecology areas.
Chief Operating Officer
Alastair has over 25 years of Product Marketing, Development, Manufacturing and Sales experience within both corporate and start-up environments. He joined DYSIS Medical from Optos plc where he served as the European General Manager, Global Product Director and was a member of the Senior Management team that floated the company on the main London market in 2006. Prior to joining Optos Mr Atkinson had an 18 year career with Hewlett Packard holding a number of national and international positions. He has a BSc from Reading University, an MSc from Bristol University and completed the Advanced Management Program at INSEAD.
Chief Financial Officer
Dave joined the DYSIS Medical team in March 2020. Prior to DYSIS, Dave was the VP of Finance and Accounting at Augmenix, Inc., which was sold to Boston Scientific at the end of 2018; Dave stayed at Boston Scientific until early 2020 as VP of Finance to help guide the successful transition and integration of the acquisition. Prior to Augmenix, Dave was with Haemonetics Corporation as head of Global Financial Planning & Analysis, and previously had held Finance, Marketing, New Business Development, and Strategic Planning roles at Boston Scientific Corporation and Staples, Inc. Dave earned a BA in Economics from the University of Pennsylvania, and an MBA in Finance and Strategic Management from The Wharton School at the University of Pennsylvania.
Sr. VP Commercial Operations
Brent joined DYSIS Medical in March of 2019 as Senior Vice President of Sales and Marketing managing the global commercial organization. Brent previously spent 15 years at Boston Scientific where he held multiple commercial positions with increasing responsibilities. Most recently, Brent was Area Vice President of Boston Scientific’s National Accounts team. Brent also served as the Director of Marketing and Commercial Integration where he oversaw the commercial development of over 25 devices during his time in marketing. Prior to Boston Scientific Brent spent 7 years at Black and Decker in various sales and marketing positions.